Amaero Delivers Record Revenue Growth as Commercial Momentum Accelerates
Amaero Inc. (ASX:3DA) delivered a record quarterly performance for the period ended 30 June 2026, reporting fourth-quarter revenue of AU$7.8 million, up 417% from the previous corresponding period. Full-year revenue reached AU$18.1 million, representing a 376% increase year-on-year and aligning with the company’s FY2026 guidance. The company ended the quarter with a contracted backlog of AU$14.6 million, which increased to AU$23.1 million after securing additional contracts following quarter-end.
Operationally, Amaero completed its three-year AU$72 million manufacturing expansion by commissioning its third EIGA Premium Atomizer, significantly increasing titanium powder production capacity. The company also signed new supply agreements, secured defence-related contracts, resumed titanium powder production after a temporary safety-led suspension, and completed its corporate redomiciliation to the United States. Management enters FY2027 with expanded manufacturing capabilities, growing commercial demand, and a focus on converting its order pipeline into sustainable long-term revenue.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Amaero Delivers Record Revenue Growth as Commercial Momentum Accelerates
Amaero Inc. (ASX:3DA) delivered a record quarterly performance for the period ended 30 June 2026, reporting fourth-quarter revenue of AU$7.8 million, up 417% from the previous corresponding period. Full-year revenue reached AU$18.1 million, representing a 376% increase year-on-year and aligning with the company’s FY2026 guidance. The company ended the quarter with a contracted backlog of AU$14.6 million, which increased to AU$23.1 million after securing additional contracts following quarter-end.
Operationally, Amaero completed its three-year AU$72 million manufacturing expansion by commissioning its third EIGA Premium Atomizer, significantly increasing titanium powder production capacity. The company also signed new supply agreements, secured defence-related contracts, resumed titanium powder production after a temporary safety-led suspension, and completed its corporate redomiciliation to the United States. Management enters FY2027 with expanded manufacturing capabilities, growing commercial demand, and a focus on converting its order pipeline into sustainable long-term revenue.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au